Loading
HETERO HEALTHCARE launches GABAQUIL for management of “Painful Diabetic Neuropathy”
HETERO HEALTHCARE launches GABAQUIL for management of “Painful Diabetic Neuropathy”
Gabapentin & Lidocaine in Gabaquil helps in subsiding the excruciating pain which patient experiences
48th National Safety Week Campaign
48th National Safety Week Campaign
Hetero Healthcare has taken an initiative and conducted 48th National Safety Week Campaign
Hetero Launches Generic Breast Cancer Treatment Drug in India
Hetero Launches Generic Breast Cancer Treatment Drug in India
Hetero has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country
Sharing Smiles
Sharing Smiles
Come and Join hands with us towards noble cause for "Sharing Smiles"
THE OSKAR NIGHT
THE OSKAR NIGHT
Hetero Healthcare on its part celebrates the success of FY 2017 -2018, by presenting THE OSKAR NIGHT
Infrastructure

Hetero Health Care R & D Centre had developed across a vast area. A striking feature of Hetero Health care is the well-planned and comprehensive infrastructure provided

Research & Development

One of the world leaders in developing and manufacturing a wide range of brands/non-brands generics including oncology and ARV drugs

Achievements

Basic manufacturer of Oseltamivir (sub-licencing agreement with Hoffmann-La Rosche, Switzerland) Launched biosimilar Rituximab for treatment of chronic leukaemia

Innovation Drives Progress

When it comes to innovation in the development of new drugs and therapeutic biological products company is completely focused structuring the Molecule need of the industry Innovation Strategy.

Doctors
Formulation Products
+
Field Force

Hetero Healthcare - Innovative Pharmaceutical Company

We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists .